Burcon Nutrascience Corporation
BU.TO
TSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 246.50K | 202.60K | 310.30K | 137.40K | 137.40K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 246.50K | 202.60K | 310.30K | 137.40K | 137.40K |
| Cost of Revenue | 477.70K | 272.40K | 155.10K | -- | -- |
| Gross Profit | -231.20K | -69.80K | 155.20K | 137.40K | 137.40K |
| SG&A Expenses | 3.04M | 3.05M | 2.96M | 2.78M | 2.64M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.78M | 5.85M | 5.48M | 5.34M | 5.26M |
| Operating Income | -5.53M | -5.65M | -5.17M | -5.20M | -5.13M |
| Income Before Tax | -5.96M | -6.18M | -5.52M | -5.58M | -5.38M |
| Income Tax Expenses | -57.70K | -57.70K | -57.70K | -57.70K | -42.40K |
| Earnings from Continuing Operations | -5.90 | -6.12 | -5.46 | -5.52 | -5.34 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -5.90M | -6.12M | -5.46M | -5.52M | -5.34M |
| EBIT | -5.53M | -5.65M | -5.17M | -5.20M | -5.13M |
| EBITDA | -5.29M | -5.42M | -4.96M | -5.00M | -4.95M |
| EPS Basic | -0.04 | -0.05 | -0.04 | -0.05 | -0.05 |
| Normalized Basic EPS | -0.03 | -0.03 | -0.03 | -0.03 | -0.01 |
| EPS Diluted | -0.04 | -0.05 | -0.04 | -0.05 | -0.05 |
| Normalized Diluted EPS | -0.03 | -0.03 | -0.03 | -0.03 | -0.01 |
| Average Basic Shares Outstanding | 553.09M | 532.15M | 511.65M | 485.55M | 468.08M |
| Average Diluted Shares Outstanding | 553.09M | 532.15M | 511.65M | 485.55M | 468.08M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
